Screener
Praxis Precision Medicines, Inc. PRAX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from at-the-market offerings, net of issuance and commission costs | — | 83,263 |
| Payments of tax withholdings related to vesting of restricted stock units | (13,233) | (1,218) |
| Proceeds from exercise of stock options and employee stock purchase plan purchases | 6,001 | 854 |
| Net cash provided by financing activities | 614,003 | 82,899 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 117,016 | (57,957) |
| Cash, cash equivalents and restricted cash, beginning of period | 357,745 | 215,788 |
| Cash, cash equivalents and restricted cash, end of period | $474,761 | $157,831 |
| Reconciliation of cash, cash equivalents and restricted cash: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s financing cash flow?
- Praxis Precision Medicines, Inc. (PRAX) reported financing cash flow of $4.57M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s financing cash flow changed year-over-year?
- Praxis Precision Medicines, Inc.'s financing cash flow decreased by 84.0% year-over-year, from $28.63M to $4.57M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s financing cash flow has grown at a 59.8% compound annual growth rate (CAGR), from $107.59M to $702.17M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Praxis Precision Medicines, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude